Primary study · included by 1 review

RANKL inhibition for giant cell lesions of the jaw: A retrospective cohort analysis.

Schreuder et al. 2022 · Schreuder Willem H, Lipplaa Astrid, Cleven Arjen H G, et al. · European journal of cancer (Oxford, England : 1990) · 2022

Included by

RANK/RANKL/OPG Axis Expression and Response to Anti-RANKL Therapy in Gnathic Giant Cell Lesions: A Systematic Review and Meta-Analysis.
Non-Cochrane · other · 2026 · cited as Schreuder 2022 · Table 2; Table 1 / Table 4; reference list
Outcome this study informsPooled effectEvidenceCertainty
Clinical and radiological tumor response
Denosumab
no estimate extracted10 studies · 58 participantsGRADE not reported

1 including review in total.